+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 0 - 28Days
All Genders
ID07322133

Comparing Dopamine and Norepinephrine for Low Blood Pressure in Term and Late Preterm Newborns with Pulmonary Hypertension and Respiratory Failure

Led by University of California, Davis · Updated on 2026-08-18

30

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating dopamine and norepinephrine as first-line vasoactive treatments for term and late preterm newborns with pulmonary hypertension combined with hypoxemic respiratory failure and low blood pressure. This pilot randomized clinical trial aims to compare short-term effects of these treatments on heart and lung function. Pulmonary hypertension causes high blood vessel resistance in the lungs, leading to oxygen problems and risks for newborns. Dopamine is commonly used but may increase lung resistance, while norepinephrine might raise systemic blood pressure with less impact on the lungs. The study involves term and late preterm infants showing lung hypertension and low blood pressure despite receiving fluids. Participants are randomly assigned by time periods to receive either dopamine or norepinephrine as their first vasopressor. Dopamine starts at 5 mcgkgmin, increasing up to 20 mcgkgmin, while norepinephrine starts at 0.02 mcgkgmin, increasing up to 1 mcgkgmin, both adjusted to reach blood pressure targets appropriate for the infants age. Medication use follows standard clinical protocols, and informed consent is obtained for research procedures including repeated heart ultrasound scans. During the study, infants receive serial heart ultrasounds and oxygen measurements to assess blood pressure ratios, heart output, and oxygen levels within 30 hours of starting treatment. Researchers also monitor use of inhaled nitric oxide, need for additional medications, and heart function markers. The trial is conducted at a single center, with study completion expected in June 2027. This research helps understand how these medications affect newborn heart and lung health in pulmonary hypertension with low blood pressure.

CONDITIONS

Brief Title

Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)

Research Team

S

Solomon P Tatagiri, MBBS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here